Indivior reported 89M in Net Income for its fiscal semester ending in March of 2026.





Net Income Change Date
AstraZeneca USD 2.51B 573M Jun/2026
Cassava Sciences USD -10.33M 2.21M Mar/2026
GlaxoSmithKline GBP 435M 1.3B Jun/2026
Glaxosmithkline GBP 1.74B 890.94M Mar/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Roche Holding CHF 6.87B 1.4B Jun/2026
West Pharmaceutical Services USD 154M 15.2M Jun/2026